Literature DB >> 19690871

Myoblast transplantation to defecation muscles in a rat model: a possible treatment strategy for fecal incontinence after the repair of imperforate anus.

Ryoko Saihara1, Hiroaki Komuro, Yasuhisa Urita, Kouki Hagiwara, Michio Kaneko.   

Abstract

PURPOSE: Infants with higher anorectal anomalies often develop fecal incontinence after surgical reconstruction mainly due to the incomplete development of defecation muscles. We investigated the possibility of defecation muscle regeneration by myoblast transplantation to improve fecal continence.
METHODS: Myoblasts from F344 female rats at ages of 1 day, 1, 2, 3, 4, 8, and 12 weeks were prepared by a preplating method. In vivo muscle differentiation of myoblasts was evaluated using immunofluorescence after transplantation of GFP-positive myoblasts into nude mice, the damaged thigh muscles, and the levator ani muscle of GFP-negative rats.
RESULTS: The ratios of myoblasts obtained from 1 day, 1, 2, 3, 4, 8, and 12-week-old rats were 35, 71, 65, 61, 52, 44, and 23%, respectively. Myotube formation by transplanted myoblasts was observed in the back of nude mice. Myoblasts transplanted into damaged thigh muscles were integrated into recipient muscles with myofiber formation. Transferred myoblasts formed myotubes surrounding the levator ani muscle, although myofiber formation was not observed.
CONCLUSION: Myoblasts were most efficiently obtained from juvenile rats. Myoblast transplantation may provide a novel treatment strategy for improving fecal continence after repair of anorectal anomalies in infants.

Entities:  

Mesh:

Year:  2009        PMID: 19690871     DOI: 10.1007/s00383-009-2454-3

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  17 in total

1.  Primary rat muscle progenitor cells have decreased proliferation and myotube formation during passages.

Authors:  S Machida; E E Spangenburg; F W Booth
Journal:  Cell Prolif       Date:  2004-08       Impact factor: 6.831

2.  Satellite-cell pool size does matter: defining the myogenic potency of aging skeletal muscle.

Authors:  Gabi Shefer; Daniel P Van de Mark; Joshua B Richardson; Zipora Yablonka-Reuveni
Journal:  Dev Biol       Date:  2006-03-22       Impact factor: 3.582

Review 3.  Stem cell review series: aging of the skeletal muscle stem cell niche.

Authors:  Suchitra D Gopinath; Thomas A Rando
Journal:  Aging Cell       Date:  2008-06-28       Impact factor: 9.304

4.  Developmental fate of skeletal muscle satellite cells.

Authors:  B H Lipton; E Schultz
Journal:  Science       Date:  1979-09-21       Impact factor: 47.728

5.  Cellular and molecular reactions in mouse muscles after myoblast implantation.

Authors:  A Irintchev; M Zweyer; A Wernig
Journal:  J Neurocytol       Date:  1995-04

6.  Human myoblasts as antigen-presenting cells.

Authors:  N Goebels; D Michaelis; H Wekerle; R Hohlfeld
Journal:  J Immunol       Date:  1992-07-15       Impact factor: 5.422

7.  Improvement of urethral sphincter deficiency in female rats following autologous skeletal muscle myoblasts grafting.

Authors:  Christophe Praud; Philippe Sebe; Anne-Sophie Biérinx; Alain Sebille
Journal:  Cell Transplant       Date:  2007       Impact factor: 4.064

8.  Anorectal malformations.

Authors:  A Peña
Journal:  Semin Pediatr Surg       Date:  1995-02       Impact factor: 2.754

9.  Improved sphincter contractility after allogenic muscle-derived progenitor cell injection into the denervated rat urethra.

Authors:  Tracy W Cannon; Ji Youl Lee; George Somogyi; Ryan Pruchnic; Christopher P Smith; Johnny Huard; Michael B Chancellor
Journal:  Urology       Date:  2003-11       Impact factor: 2.649

10.  Development of approaches to improve the healing following muscle contusion.

Authors:  C Kasemkijwattana; J Menetrey; G Somogyl; M S Moreland; F H Fu; B Buranapanitkit; S C Watkins; J Huard
Journal:  Cell Transplant       Date:  1998 Nov-Dec       Impact factor: 4.139

View more
  6 in total

1.  Novel approach to treat fecal incontinence with muscle stem cell-based therapy.

Authors:  M Siemionow
Journal:  Tech Coloproctol       Date:  2015-11       Impact factor: 3.781

Review 2.  Faecal incontinence: Current knowledges and perspectives.

Authors:  Alban Benezech; Michel Bouvier; Véronique Vitton
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

3.  Coadministration of basic fibroblast growth factor-loaded polycaprolactone beads and autologous myoblasts in a dog model of fecal incontinence.

Authors:  Heung-Kwon Oh; Hye Seung Lee; Jin Ho Lee; Se Heang Oh; Jae-Young Lim; Soyeon Ahn; Sung-Bum Kang
Journal:  Int J Colorectal Dis       Date:  2015-01-17       Impact factor: 2.571

4.  Injection of porous polycaprolactone beads containing autologous myoblasts in a dog model of fecal incontinence.

Authors:  Sung-Bum Kang; Hye Seung Lee; Jae-Young Lim; Se Heang Oh; Sang Joon Kim; Sa-Min Hong; Je-Ho Jang; Jeong-Eun Cho; Sung-Min Lee; Jin Ho Lee
Journal:  J Korean Surg Soc       Date:  2013-03-26

Review 5.  Stem cell therapy for faecal incontinence: Current state and future perspectives.

Authors:  Jacobo Trébol; Ana Carabias-Orgaz; Mariano García-Arranz; Damián García-Olmo
Journal:  World J Stem Cells       Date:  2018-07-26       Impact factor: 5.326

6.  Fabrication of hybrid scaffolds obtained from combinations of PCL with gelatin or collagen via electrospinning for skeletal muscle tissue engineering.

Authors:  Victor Perez-Puyana; Paul Wieringa; Yaiza Yuste; Fernando de la Portilla; Antonio Guererro; Alberto Romero; Lorenzo Moroni
Journal:  J Biomed Mater Res A       Date:  2021-03-05       Impact factor: 4.396

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.